Bioequivalence Study of Quinapril Hydrochloride 20 mg and Hydrochlorothiazide 25 mg Tablets Under Fasting Conditions
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The study was conducted as a open-label, balanced, randomized, two-treatment, two-period,
two-sequence, single-dose, crossover, bioavailability study comparing Quinapril hydrochloride
and Hydrochlorothiazide tablets 20 mg/25 mg of OHM Laboratories Inc (a subsidiary of Ranbaxy
pharmaceuticals Inc) with AccureticTM tablets 20 mg/ 25 mg (containing quinapril
hydrochloride 20 mg and hydrochlorothiazide 25 mg) manufactured by Parke Davis
Pharmaceuticals Limited, Vega Baja, PR 00694, Made in Germany and distributed by Parke-Davis,
Division of Pfizer Inc. NY, NY 10017 in healthy, adult, male, human subjects under fasting
condition.